CareCloud Increases 2025 Revenue Guidance Following Medsphere Acquisition
MWN-AI** Summary
CareCloud, Inc. (NASDAQ: CCLD, CCLDO) announced a significant increase in its 2025 revenue guidance to between $116 million and $118 million, up from an earlier range of $111 million to $114 million, following the acquisition of Medsphere Systems Corporation's assets on August 22, 2025. This adjustment reflects CareCloud’s strengthened market position and heightened engagement in the hospital IT sector. The company also forecasts 2026 revenue to range from $128 million to $130 million, driven by opportunities for cross-selling, heightened hospital adoption of their products, and ongoing investment in artificial intelligence (AI) innovations.
Stephen Snyder, Co-CEO of CareCloud, highlighted the positive impact of the Medsphere acquisition, noting the growing demand for their expanded product offerings. The company’s AI Center of Excellence is rapidly developing solutions aimed at automating revenue cycle workflows, thereby supporting clinicians efficiently. These advancements are expected to enhance operational performance, improve financial stability, and bolster patient outcomes throughout healthcare services.
Despite the optimistic revenue projections, CareCloud anticipates no changes to its Adjusted EBITDA outlook. However, GAAP EPS might experience limitations due to increased non-cash amortization related to the acquisition. Detailed guidance regarding these financial metrics will be released alongside the Q3 2025 earnings.
CareCloud remains committed to delivering innovative healthcare solutions, empowering over 40,000 providers to enhance patient care while minimizing operational burdens. The company continues to focus on various solutions, including revenue cycle management (RCM), electronic health records (EHR), and patient experience management (PXM). As CareCloud moves forward, it will maintain its emphasis on disciplined innovation to navigate the evolving healthcare landscape.
MWN-AI** Analysis
CareCloud, Inc. has recently enhanced its 2025 revenue guidance to $116-$118 million, following the strategic acquisition of Medsphere Systems Corporation. This upward revision from an earlier estimate of $111-$114 million demonstrates the company’s solidification in the hospital IT market, leveraging greater scale and an expanded product portfolio. The anticipated revenue for 2026, projected at $128-$130 million, suggests continued bullish momentum driven by cross-selling opportunities and heightened adoption of their AI-assisted solutions in healthcare.
Investors should note the potential of CareCloud's AI innovations, which aim to automate essential healthcare workflows and enhance clinical efficiencies. These developments can significantly improve not only financial metrics but also patient care outcomes, making the company attractive to institutional investors focused on the growing intersection of healthcare and technology.
Despite the positive outlook, it's imperative to remain cautious. The projected GAAP EPS is expected to be impacted by increased non-cash amortization expenses from the acquisition. Investors should also keep an eye on the company's future guidance regarding Adjusted EBITDA, which has not been altered, as this will provide further insights into operational performance post-acquisition.
In summary, CareCloud presents a compelling investment opportunity, especially as the market increasingly values healthcare technology that improves operational efficiencies and clinical outcomes. However, potential investors should weigh the projected growth against operational risks associated with managing a recent acquisition and ongoing integration efforts. Keeping a close watch on quarterly earnings and management insights will be key to evaluating whether CareCloud can effectively execute its growth strategy in this rapidly evolving sector.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Company Raises 2025 Revenue Outlook to $116 –$118 Million; Expects 2026 Revenue to be $128 –$130 Million
SOMERSET, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions for hospitals and medical practices nationwide, today announced updated financial guidance following the August 22, 2025 closing of its acquisition of the business assets of Medsphere Systems Corporation (“Medsphere”).
For the full year 2025, CareCloud now expects revenue in the range of $116 million to $118 million, compared to its prior guidance of $111 million to $114 million, reflecting increased scale and expanded participation in the hospital IT market. The Company also anticipates that full year 2026 revenue will be $128 million to $130 million, supported by anticipated cross-selling opportunities, expanded hospital adoption, and continued investment in AI innovation. Further detailed guidance, including Adjusted EBITDA and earnings per share (“EPS”) will be provided in connection with the Company’s third quarter 2025 earnings release. The Company currently anticipates no change to its Adjusted EBITDA outlook, though GAAP EPS is expected to be impacted by higher non-cash amortization expense due to the acquisition.
“This increase in revenue guidance underscores the strong momentum generated by our transformative acquisition of Medsphere and the market demand we are seeing across our expanded product portfolio,” said Stephen Snyder, Co-Chief Executive Officer of CareCloud. “We are excited by the opportunities ahead as we bring CareCloud’s AI-driven solutions to both ambulatory and inpatient providers nationwide.”
“Our AI Center of Excellence is rapidly advancing tools that automate revenue cycle workflows and support clinicians in real time,” said A. Hadi Chaudhry, Co-Chief Executive Officer of CareCloud. “These innovations are designed to improve efficiency, strengthen financial performance, and enhance patient outcomes across the care continuum.”
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com .
Follow CareCloud on LinkedIn , X and Facebook .
For additional information, please visit our website at carecloud.com . To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com .
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions. Past operational or stock price performance is not an indication of future performance.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE: CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Stephen Snyder
Co-Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com
FAQ**
How does CareCloud Inc. anticipate the acquisition of Medsphere Systems Corporation will specifically impact the expected increase in revenue for 2025 and 2026, particularly for those holding "CareCloud Inc. 1Series A Cumulative Redeemable Perpetual Preferred Stock CCLDP"?
What strategic initiatives is CareCloud implementing to leverage cross-selling opportunities post-acquisition, and how might this affect the performance of "CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock CCLDP"?
Can CareCloud provide more details on the expected higher non-cash amortization expenses that will impact GAAP EPS and how this may relate to the benefits for holders of "CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock CCLDP"?
What specific innovations is CareCloud introducing through its AI Center of Excellence, and how do these developments support the revenue growth outlook for 2025 and 2026 for "CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock CCLDP"?
**MWN-AI FAQ is based on asking OpenAI questions about CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock (NASDAQ: CCLDP).
NASDAQ: CCLDP
CCLDP Trading
-10.6% G/L:
$19.43 Last:
23,210 Volume:
$21.49 Open:
